Access to the newest treatments...

At absolutely no cost for treatment...

Closely monitored by a leading physician...

Clinical Research opens up new possibility for your treatment.


Volunteer Medical Research

Meet the leaders in Kidney Disease & Hypertension Clinical Research

Beth Jackman, LPN, CCRC

Study Coordinator

Candy Leak

Study Coordinator

Clinical Trials: Why not being on the cutting edge of medical treatment?

Don’t hesitate to reach out with your questions: (941) 258-3556

Site Specifics

Volunteer Medical Research is located on the 2nd floor of a two-story building. The first floor is the nephrology private practice of Kianoosh Kaveh, DO, Rohit Pankhaniya, MD, and Nandheesha Hanumanthappa, MD.

Staff: Investigators (list not inclusive):

Kianoosh Kaveh, DO
Board-Certified Nephrology/Internal Medicine

Rohit Pankhaniya, MD
Board-Certified Nephrology/Internal Medicine

Usha Chandrahasa, MD
Board-Certified Allergy/Immunology

Nandheesha Hanumanthappa, MD
Board-Certified Nephrology/Internal Medicine

VMR Rooms (dedicated to research):

  • 3 exam rooms
  • 1 locked regulatory room
  • 1 locked study-coordinator room
  • 1 monitor area
  • 1 lab
  • 1 storage room (lab kits)
  • 1 locked IP room with refrigerator
  • locked ambient cabinets


  • 3 beam scales
  • 1 Burdick ELI 230 EKG AT-2 machine
  • 1 room-temperature centrifuges,
  • Koko PFT Spirometry System,
  • -20C (non-auto defrost) freezer
  • refrigerator, min/max thermometers
  • manual and auto-BP
  • computers/internet access for web-based data capture and study sites
  • wi-fi internet access is available for monitors


To date, our site has not been FDA audited. We do not have a local IRB and can use any Central IRB the sponsor chooses. We require the CTA agreed upon and signed by all parties prior to Regulatory start-up documents being completed. ICF and other subject document are needed in English Only.

Source Documentation:

Paper source is utilized at our site.

Inquire about our site availability.

Sponsors and/or CROs should contact us directly. Email us

Currently Enrolling Studies

  • Anemia
  • ADPKD (Autosomal Dominant Polycystic Kidney Disease)
  • Metabolic Acidosis
  • Diabetes Mellitus Type 2
  • FSGS
  • Hyperuricemia

Learn details of each study.

Frequently Asked Questions

Some things you should know before you participate...

What is research?

Research is the collection and analyzing of data that is done in order to answer a question.

What kinds of procedures are involved?

Research studies can involve a wide variety of procedures, ranging from filling out surveys and questionnaires to taking experimental medicines or using experimental devices. Some research studies last only a few minutes, while others last for several years. The research team will describe to you all of the procedures that you will be asked to undergo before you agree to be in a study.

Who can participate in a research study?

Most research studies have certain requirements that must be met in order for a subject to participate. These requirements are designed to ensure the safety of the subjects and the usefulness of the research.  Some studies have broad requirements such as being over the age of 18. Other studies have a more focused requirements such as having a certain disease or condition.

Do I have to participate?

No! Participating in a research study is voluntary. Research participants have the right to discontinue the study at any time. Refusing to participate in a study will not result in a penalty or loss of any benefits to which you are entitled.

Are there risks to being in a research study?

Research may involve different types of risk. The research team is required to explain to you the foreseeable risks of being in a study before you decide whether or not to participate.

Experience, knowledge and skill...

``Why we love working in research... our small team works well together to bring our patients the best outcome possible. We have the research experience, knowledge, and skills needed. We are compassionate, friendly, and approachable. We want our patients to feel at ease and have an enjoyable experience while they participate in our clinical trials. The best part about our jobs is the patients and the relationship we get to build with them, because of the quality time we get to spend with them. It is so rewarding when our contribution to research makes a positive impact on our patient's lives and lives around the world!``

What exactly do we study?

We are currently enrolling patients that have been diagnosed with the following conditions:
  • Anemia
  • ADPKD (Autosomal Dominant Polycystic Kidney Disease)
  • FSGS
  • Metabolic Acidosis
  • Diabetes Mellitus Type 2
  • Hyperuricemia

``I was treated more akin to a friend who needed assistance than as a mere subject of a study...``

Brion Sever, VMR Clinical Patient since 2012
Being a subject in a research study requires a great deal of patience and flexibility from the volunteer, with typically very little in return beyond the satisfaction of helping the field progress so that it can aid future generations. Due to my disease, I have been a part of several research studies and I have been treated very well in each study. The team at Volunteer Medical Research, however, seemed to understand better than any other facility about the sacrifices that are being made by the volunteers in their studies. I never felt like just a subject of a study at Volunteer Medical Research, as they conveyed sincere appreciation for my volunteer work and I was treated more akin to a friend who needed assistance than as a mere subject of a study. A group of their staff even traveled a significant distance one year to support a walk for PKD that I was attending! Thus, I would like to thank all of the staff at Volunteer Medical Research, Beth Jackman in particular, for their tremendous support over the past six years!

Currently Enrolling Trials

If you do decide to take part in a study, there is a process of intake that needs to be undergone with our study coordinator. This website is for informational purposes only and is subject to change.
Principal Investigator- Kianoosh Kaveh DO

A phase 3 randomized, open-label (sponsor-blind), active-controlled, parallel-group, multi-center, event driven study in non-dialysis subjects with anemia associated with chronic kidney disease to evaluate the safety and efficacy of daprodustat compared to darbepoetin alfa.

You have been asked to take part in a clinical trial, a type of research study, which we shall refer to as a “study”. This consent form has been reviewed by Quorum Review, an Independent Review Board (IRB). This board reviews research studies to protect the rights and well-being of the people taking part.

Kianoosh Kaveh, DO
Reata Corporation, LLC

FALCON is a Phase 3 clinical study evaluating the effectiveness and safety of bardoxolone methyl (an oral investigational drug) in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Bardoxolone methyl is a capsule taken by mouth that has been tested in many clinical studies with different diseases.

In prior trials, bardoxolone methyl has consistently improved parameters of kidney function in some patients with CKD, cancer, and pulmonary hypertension.

Principal Investigator- Kianoosh Kaveh, DO

VALOR is a Phase 3b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of TRC101 in Delaying Chronic Kidney Disease Progression in Subjects with Metabolic Acidosis

You are being asked to volunteer to take part in a research study because you have kidney disease and a lower than normal level of bicarbonate in your blood. Kidney disease causes the kidneys to function less well and to retain acid in the blood causing a condition called “metabolic acidosis”. Blood that has too much acid can cause problems with bone, muscles, and other body functions. Low blood bicarbonate may also contribute to worsening of kidney function. When there is too much acid in the blood, the blood bicarbonate level goes down, below the normal range. Increasing the blood bicarbonate level makes the level of acid in the blood go down

Kianoosh Kaveh, DO
AstraZeneca AB

A Phase 2b, Multicentre, Randomised, Double-blind, Placebo-controlled Study of Verinurad and Allopurinol in Patients with Chronic Kidney Disease and Hyperuricemia.

This study is designed to see if the new investigational drug called ‘Verinurad’, which is not approved by any health authority (such as, the U.S. Food and Drug Administration `{`(FDA`}`), is safe and effective in reducing the amount of a protein called albumin in your urine when given in combination with an approved drug called Allopurinol.

Rohit Pankhaniya, MD
Retrophin, Inc

Focal Segmental Glomerulosclerosis (FSGS) is a rare disease that affects the kidneys in both adults and children. Kidneys are important to your health because they filter waste materials such as salts, toxins and water out of the blood. The waste is passed out of your body as urine (pee). FSGS causes scarring in parts of the kidney that filter these waste materials, allowing protein to leak into the urine. The leaking protein is a condition called proteinuria and it causes fluid to build up in the body. If the protein leaks for too long, it can eventually lead to kidney failure (kidneys stop working).

You are being asked to join this research study involving the investigational drug, sparsentan, because you have been diagnosed with FSGS. An investigational drug means that not all information is known about how the drug works in your body and it has not been approved by the Food and Drug Administration (FDA) for the treatment of FSGS.

Contact Us Directly to Apply

Connect directly with a study coordinator during normal business hours. We look forward to the opportunity to walk with you in the journey of clinical research.